iofetamine has been researched along with Ambulation Disorders, Neurologic in 3 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazui, H | 2 |
| Mori, E | 1 |
| Ohkawa, S | 1 |
| Okada, T | 1 |
| Kondo, T | 1 |
| Sakakibara, R | 1 |
| Ueki, O | 1 |
| Nishio, Y | 1 |
| Ishii, K | 1 |
| Kawaguchi, T | 1 |
| Ishikawa, M | 1 |
| Takeda, M | 2 |
| Takaya, M | 1 |
| Tokunaga, H | 1 |
| Yoshida, T | 1 |
| Kito, Y | 1 |
| Wada, T | 1 |
| Nomura, K | 1 |
| Shimosegawa, E | 1 |
| Hatazawa, J | 1 |
| Imamura, K | 1 |
| Okayasu, N | 1 |
| Nagatsu, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Depletive Lumbar Puncture and Cerebrospinal Fluid Shunt Surgery on Lower Urinary Tract Dysfunction in Normal Pressure Hydrocephalus[NCT03877107] | 100 participants (Anticipated) | Interventional | 2019-03-13 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for iofetamine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cerebrospinal Fluid Shunts; Cerebrovascular Circulati | 2013 |
Global cerebral hypoperfusion in preclinical stage of idiopathic normal pressure hydrocephalus.
Topics: Aged; Aged, 80 and over; Autoradiography; Cerebrovascular Disorders; Cognition Disorders; Disease Pr | 2010 |
Cerebral blood flow and freezing of gait in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cerebrovascular Circulation; Disability Evaluation; D | 2012 |